Takeda Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This report of Takeda Pharmaceutical Co Ltd leverages intelligence from across the web and also from available disclosures by Takeda Pharmaceutical Co Ltd. This page includes a Q&A section about Takeda Pharmaceutical Co Ltd. Other corporations in the rating industry group for Takeda Pharmaceutical Co Ltd are shownin the table.
Takeda Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 7.0, social score of 8.0 and governance score of 5.7.
6.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
290 | Qiagen NV | 7.0 | High |
290 | WuXi AppTec Co Ltd | 7.0 | High |
294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
294 | Cabaletta Bio Inc | 6.9 | High |
294 | Bicycle Therapeutics PLC | 6.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Takeda Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Takeda Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Takeda Pharmaceutical Co Ltd report the average age of the workforce?
Does Takeda Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Takeda Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Takeda Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Takeda Pharmaceutical Co Ltd offer flexible work?
Does Takeda Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Takeda Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Takeda Pharmaceutical Co Ltd conduct supply chain audits?
Does Takeda Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Takeda Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Takeda Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Takeda Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Takeda Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Takeda Pharmaceutical Co Ltd disclose water use targets?
Does Takeda Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Takeda Pharmaceutical Co Ltd have a product recall in the last two years?
Does Takeda Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Takeda Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Takeda Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Takeda Pharmaceutical Co Ltd disclose parental leave metrics?
Does Takeda Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Takeda Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Takeda Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Takeda Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Takeda Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Takeda Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Takeda Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Takeda Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Takeda Pharmaceutical Co Ltd disclose its waste policy?
Does Takeda Pharmaceutical Co Ltd report according to TCFD requirements?
Does Takeda Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Takeda Pharmaceutical Co Ltd disclose energy use targets?
Does Takeda Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Takeda Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Takeda Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.